0000899243-20-014282.txt : 20200526 0000899243-20-014282.hdr.sgml : 20200526 20200526212741 ACCESSION NUMBER: 0000899243-20-014282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200521 FILED AS OF DATE: 20200526 DATE AS OF CHANGE: 20200526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hunt Anthony CENTRAL INDEX KEY: 0001606030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 20912595 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-21 0 0000730272 REPLIGEN CORP RGEN 0001606030 Hunt Anthony C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 1 0 0 Chief Executive Officer Common Stock 2020-05-21 4 M 0 7916 16.55 A 238157 D Common Stock 2020-05-21 4 M 0 39037 24.98 A 277194 D Common Stock 2020-05-21 4 S 0 16496 139.17 D 260698 D Common Stock 2020-05-21 4 S 0 28980 140.04 D 231718 D Common Stock 2020-05-21 4 S 0 1377 140.99 D 230341 D Common Stock 2020-05-21 4 S 0 100 141.58 D 230241 D Common Stock 2020-05-21 4 M 0 3086 32.40 A 233327 D Stock Option (Right to Buy) 16.55 2020-05-21 4 M 0 7916 0.00 D 2024-05-05 Common Stock 7916 1 D Stock Option (Right to Buy) 24.98 2020-05-21 4 M 0 39037 0.00 D 2025-02-26 Common Stock 39037 0 D Stock Option (Right to Buy) 32.40 2020-05-21 4 M 0 3086 0.00 D 2027-02-23 Common Stock 3086 50154 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on March 11, 2020. $139.17 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.52 to $139.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $140.04 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.54 to $140.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. $140.99 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.54 to $141.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. This option is currently exercisable. /s/ Jeffrey P. Leduc (Attorney in Fact) 2020-05-26